吗啉硝唑氯化钠注射液 | China Drugs ListMorinidazole and Sodium Chloride Injection | China Drugs List
本页为公开参考信息，不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。
- 企业
- 江苏豪森药业Jiangsu Hansoh Pharmaceutical
- 药品类型
- 化学药Chemical medicine
- 治疗领域
- 感染性疾病Infectious diseases
- 公开来源记录的适应症
- 用于敏感厌氧菌引起的18岁及以上成人感染：妇科盆腔炎，包括子宫内膜炎、输卵管炎、输卵管卵巢脓肿和盆腔腹膜炎；与手术联合治疗化脓性阑尾炎及坏疽性阑尾炎。对于需氧菌与厌氧菌混合感染，还需根据病情考虑对需氧菌有效的抗菌药物。本段依据成都国为同通用名仿制药说明书，原研品牌说明书全文仍待取得。For infections caused by susceptible anaerobic bacteria in adults aged 18 years and older: gynecological pelvic inflammatory disease, including endometritis, salpingitis, tubo-ovarian abscess and pelvic peritonitis; and, alongside surgery, suppurative appendicitis and gangrenous appendicitis. For mixed aerobic and anaerobic infections, an antibacterial active against aerobic organisms should also be considered according to the clinical situation. This description is based on the prescribing information for the Chengdu Gowell generic product with the same generic name; the complete originator-brand prescribing information has not yet been obtained.
- 适应症来源与口径
- 来源日期： 2025-05-09. 生产商面向中国大陆的药品说明书。 成都国为生产的仿制药说明书，并非原研品牌说明书。Source date(s): 2025-05-09. Manufacturer prescribing information for Mainland China. Generic label from Chengdu Guowei; not the originator brand.
- 说明书信息局限
- 已取得同成分仿制药的完整中文说明书。尚未取得原研品牌说明书。Complete Chinese label obtained for a generic with the same ingredient. The originator brand label remains unavailable.
- 中国可获得性状态
- 已核实中国历史批准记录；尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- 海外状态
- 待逐一核查各市场。Market-by-market verification pending.
- 医保分类
- 已纳入国家医保（乙类）Included in national insurance (Category B)
- 医保版本
- 2025版；2026年1月1日起执行2025 edition; effective 1 January 2026
- 医保限制
- 限二线用药。Limited to second-line use.
- 医保核查说明
- 按成分／剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.